发明授权
US08791159B2 Compound capable of binding S1P receptor and pharmaceutical use thereof
有权
能够结合S1P受体的化合物及其药物用途
- 专利标题: Compound capable of binding S1P receptor and pharmaceutical use thereof
- 专利标题(中): 能够结合S1P受体的化合物及其药物用途
-
申请号: US12879158申请日: 2010-09-10
-
公开(公告)号: US08791159B2公开(公告)日: 2014-07-29
- 发明人: Shinji Nakade , Hirotaka Mizuno , Takeji Ono , Masashi Minami , Hiroshi Saga , Hiroshi Hagiya , Takaki Komiya , Hiromu Habashita , Haruto Kurata , Kazuhiro Ohtsuki , Kensuke Kusumi
- 申请人: Shinji Nakade , Hirotaka Mizuno , Takeji Ono , Masashi Minami , Hiroshi Saga , Hiroshi Hagiya , Takaki Komiya , Hiromu Habashita , Haruto Kurata , Kazuhiro Ohtsuki , Kensuke Kusumi
- 申请人地址: JP Osaka
- 专利权人: Ono Pharmaceutical Co., Ltd.
- 当前专利权人: Ono Pharmaceutical Co., Ltd.
- 当前专利权人地址: JP Osaka
- 代理机构: Sughrue Mion, PLLC
- 优先权: JP2003-306088 20030829; JP2004-110573 20040402; JP2004-169958 20040608; JP2004-198523 20040705
- 主分类号: C07C227/36
- IPC分类号: C07C227/36 ; A61K31/235 ; A61K31/197
摘要:
A compound having an ability to bind to an SIP receptor and represented by formula (I), a salt thereof, a solvate thereof or a prodrug thereof is useful for prevention and/or treatment of rejection of transplantation, graft-versus-host disease, autoimmune disease, allergic disease and the like: wherein ring A is a cyclic group; ring B is a cyclic group which may have substituent(s); X is a spacer having 1 to 8 atoms in its main chain, etc.; Y is a spacer having 1 to 10 atoms in its main chain, etc.; n is 0 or 1, wherein when n is 0, m is 1 and R1 is a hydrogen atom or a substituent, and wherein when n is 1, m is 0 or an integer of 1 to 7 and R1 is a substituent, and wherein m is 2 or more, R1s are the same or different.
公开/授权文献
信息查询